Cargando…

Molecular Epidemiology and Evolution of European Bat Lyssavirus 2

Bat rabies cases in Europe are mainly attributed to two lyssaviruses, namely European Bat Lyssavirus 1 (EBLV-1) and European Bat Lyssavirus 2 (EBLV-2). Prior to the death of a bat worker in Finland in 1985, very few bat rabies cases were reported. Enhanced surveillance in the two subsequent years (1...

Descripción completa

Detalles Bibliográficos
Autores principales: McElhinney, Lorraine M., Marston, Denise A., Wise, Emma L., Freuling, Conrad M., Bourhy, Hervé, Zanoni, Reto, Moldal, Torfinn, Kooi, Engbert A., Neubauer-Juric, Antonie, Nokireki, Tiina, Müller, Thomas, Fooks, Anthony R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796105/
https://www.ncbi.nlm.nih.gov/pubmed/29303971
http://dx.doi.org/10.3390/ijms19010156
_version_ 1783297434120617984
author McElhinney, Lorraine M.
Marston, Denise A.
Wise, Emma L.
Freuling, Conrad M.
Bourhy, Hervé
Zanoni, Reto
Moldal, Torfinn
Kooi, Engbert A.
Neubauer-Juric, Antonie
Nokireki, Tiina
Müller, Thomas
Fooks, Anthony R.
author_facet McElhinney, Lorraine M.
Marston, Denise A.
Wise, Emma L.
Freuling, Conrad M.
Bourhy, Hervé
Zanoni, Reto
Moldal, Torfinn
Kooi, Engbert A.
Neubauer-Juric, Antonie
Nokireki, Tiina
Müller, Thomas
Fooks, Anthony R.
author_sort McElhinney, Lorraine M.
collection PubMed
description Bat rabies cases in Europe are mainly attributed to two lyssaviruses, namely European Bat Lyssavirus 1 (EBLV-1) and European Bat Lyssavirus 2 (EBLV-2). Prior to the death of a bat worker in Finland in 1985, very few bat rabies cases were reported. Enhanced surveillance in the two subsequent years (1986–1987) identified 263 cases (more than a fifth of all reported cases to date). Between 1977 and 2016, 1183 cases of bat rabies were reported, with the vast majority (>97%) being attributed to EBLV-1. In contrast, there have been only 39 suspected cases of EBLV-2, of which 34 have been confirmed by virus typing and presently restricted to just two bat species; Myotis daubentonii and Myotis dasycneme. The limited number of EBLV-2 cases in Europe prompted the establishment of a network of European reference laboratories to collate all available viruses and data. Despite the relatively low number of EBLV-2 cases, a large amount of anomalous data has been published in the scientific literature, which we have here reviewed and clarified. In this review, 29 EBLV-2 full genome sequences have been analysed to further our understanding of the diversity and molecular evolution of EBLV-2 in Europe. Analysis of the 29 complete EBLV-2 genome sequences clearly corroborated geographical relationships with all EBLV-2 sequences clustering at the country level irrespective of the gene studied. Further geographical clustering was also observed at a local level. There are high levels of homogeneity within the EBLV-2 species with nucleotide identities ranging from 95.5–100% and amino acid identities between 98.7% and 100%, despite the widespread distribution of the isolates both geographically and chronologically. The mean substitution rate for EBLV-2 across the five concatenated genes was 1.65 × 10(−5), and evolutionary clock analysis confirms the slow evolution of EBLV-2 both between and within countries in Europe. This is further supported by the first detailed EBLV-2 intra-roost genomic analysis whereby a relatively high sequence homogeneity was found across the genomes of three EBLV-2 isolates obtained several years apart (2007, 2008, and 2014) from M. daubentonii at the same site (Stokesay Castle, Shropshire, UK).
format Online
Article
Text
id pubmed-5796105
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-57961052018-02-09 Molecular Epidemiology and Evolution of European Bat Lyssavirus 2 McElhinney, Lorraine M. Marston, Denise A. Wise, Emma L. Freuling, Conrad M. Bourhy, Hervé Zanoni, Reto Moldal, Torfinn Kooi, Engbert A. Neubauer-Juric, Antonie Nokireki, Tiina Müller, Thomas Fooks, Anthony R. Int J Mol Sci Review Bat rabies cases in Europe are mainly attributed to two lyssaviruses, namely European Bat Lyssavirus 1 (EBLV-1) and European Bat Lyssavirus 2 (EBLV-2). Prior to the death of a bat worker in Finland in 1985, very few bat rabies cases were reported. Enhanced surveillance in the two subsequent years (1986–1987) identified 263 cases (more than a fifth of all reported cases to date). Between 1977 and 2016, 1183 cases of bat rabies were reported, with the vast majority (>97%) being attributed to EBLV-1. In contrast, there have been only 39 suspected cases of EBLV-2, of which 34 have been confirmed by virus typing and presently restricted to just two bat species; Myotis daubentonii and Myotis dasycneme. The limited number of EBLV-2 cases in Europe prompted the establishment of a network of European reference laboratories to collate all available viruses and data. Despite the relatively low number of EBLV-2 cases, a large amount of anomalous data has been published in the scientific literature, which we have here reviewed and clarified. In this review, 29 EBLV-2 full genome sequences have been analysed to further our understanding of the diversity and molecular evolution of EBLV-2 in Europe. Analysis of the 29 complete EBLV-2 genome sequences clearly corroborated geographical relationships with all EBLV-2 sequences clustering at the country level irrespective of the gene studied. Further geographical clustering was also observed at a local level. There are high levels of homogeneity within the EBLV-2 species with nucleotide identities ranging from 95.5–100% and amino acid identities between 98.7% and 100%, despite the widespread distribution of the isolates both geographically and chronologically. The mean substitution rate for EBLV-2 across the five concatenated genes was 1.65 × 10(−5), and evolutionary clock analysis confirms the slow evolution of EBLV-2 both between and within countries in Europe. This is further supported by the first detailed EBLV-2 intra-roost genomic analysis whereby a relatively high sequence homogeneity was found across the genomes of three EBLV-2 isolates obtained several years apart (2007, 2008, and 2014) from M. daubentonii at the same site (Stokesay Castle, Shropshire, UK). MDPI 2018-01-05 /pmc/articles/PMC5796105/ /pubmed/29303971 http://dx.doi.org/10.3390/ijms19010156 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
McElhinney, Lorraine M.
Marston, Denise A.
Wise, Emma L.
Freuling, Conrad M.
Bourhy, Hervé
Zanoni, Reto
Moldal, Torfinn
Kooi, Engbert A.
Neubauer-Juric, Antonie
Nokireki, Tiina
Müller, Thomas
Fooks, Anthony R.
Molecular Epidemiology and Evolution of European Bat Lyssavirus 2
title Molecular Epidemiology and Evolution of European Bat Lyssavirus 2
title_full Molecular Epidemiology and Evolution of European Bat Lyssavirus 2
title_fullStr Molecular Epidemiology and Evolution of European Bat Lyssavirus 2
title_full_unstemmed Molecular Epidemiology and Evolution of European Bat Lyssavirus 2
title_short Molecular Epidemiology and Evolution of European Bat Lyssavirus 2
title_sort molecular epidemiology and evolution of european bat lyssavirus 2
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796105/
https://www.ncbi.nlm.nih.gov/pubmed/29303971
http://dx.doi.org/10.3390/ijms19010156
work_keys_str_mv AT mcelhinneylorrainem molecularepidemiologyandevolutionofeuropeanbatlyssavirus2
AT marstondenisea molecularepidemiologyandevolutionofeuropeanbatlyssavirus2
AT wiseemmal molecularepidemiologyandevolutionofeuropeanbatlyssavirus2
AT freulingconradm molecularepidemiologyandevolutionofeuropeanbatlyssavirus2
AT bourhyherve molecularepidemiologyandevolutionofeuropeanbatlyssavirus2
AT zanonireto molecularepidemiologyandevolutionofeuropeanbatlyssavirus2
AT moldaltorfinn molecularepidemiologyandevolutionofeuropeanbatlyssavirus2
AT kooiengberta molecularepidemiologyandevolutionofeuropeanbatlyssavirus2
AT neubauerjuricantonie molecularepidemiologyandevolutionofeuropeanbatlyssavirus2
AT nokirekitiina molecularepidemiologyandevolutionofeuropeanbatlyssavirus2
AT mullerthomas molecularepidemiologyandevolutionofeuropeanbatlyssavirus2
AT fooksanthonyr molecularepidemiologyandevolutionofeuropeanbatlyssavirus2